CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025

Rhea-AI Summary

CV Sciences (OTCQB:CVSI), a consumer wellness company focused on hemp extracts and natural ingredients, has scheduled its Q1 2025 earnings release for May 14, 2025, after market close. The company will host a conference call with investors at 1:00 p.m. Pacific Time (4:00 p.m. Eastern Time) on the same day.

Investors can access the webcast through the company's Investor Relations website or dial in directly. U.S. participants can call (877) 407-0784, while international callers should use (201) 689-8560. A replay will be available until May 21, 2025, accessible by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (international) with confirmation code 13753631.

[]

SAN DIEGO, CA / ACCESS Newswire / May 9, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the first quarter ended March 31, 2025, after the stock market closes on Wednesday, May 14, 2025. The Company will hold a conference call with the investment community at 1:00 p.m. Pacific Time (4:00 p.m. Eastern Time) that same day.

The webcast of the conference call will be available on the Investor Relations section of the Company's website at https://ir.cvsciences.com/news-events or directly at https://viavid.webcasts.com/starthere.jsp?ei=1718204&tp_key=5ae745f8b7. The webcast will be archived for approximately 30 days. Investors interested in participating in the live call can also dial (877) 407-0784 from the U.S. or international callers can dial (201) 689-8560. Please dial the conference telephone number 15 minutes prior to the start time due to increased demand for conference calls.

A telephone replay will be available approximately two hours after the call concludes and will be available through Wednesday, May 21, 2025, by dialing (844) 512-2921 from the U.S. or (412) 317-6671 from international locations, and entering confirmation code 13753631.

About CV Sciences, Inc.

CV Sciences, Inc. (OTCQB: CVSI) is a consumer wellness company specializing in nutraceuticals and plant-based foods. The Company's hemp extracts and other proven, science-backed, natural ingredients and products are sold through a range of sales channels from B2B to B2C. The Company's +PlusCBD™ branded products are sold at select retail locations throughout the U.S. and are the top-selling hemp-extract brand in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. With a commitment to science, PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. +PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. The Company also produces cannabinoid-free supplements under its +PlusHLTH™ brand, with targeted formulations to optimize health, improve performance, and increase vitality. Our Cultured Foods™ brand provides a variety of 100% plant-based food products that are distributed primarily in the EU and other select markets. Cultured Foods™ caters to individuals seeking vegan, gluten-free, or flexitarian options for a wholesome and satisfying culinary experience. In addition, the Company owns Elevated Softgels, a leading manufacturer of encapsulated softgels and tinctures for the supplement and nutrition industry. CV Sciences, Inc. has primary offices and facilities in San Diego, California, Grand Junction, Colorado, and Warsaw, Poland. Additional information is available from OTCMarkets.com or by visiting www.cvsciences.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risk and uncertainties. CV Sciences does not undertake any obligation to publicly update any forward-looking statements, except as required by applicable law. As a result, investors should not place undue reliance on such forward-looking statements.

CONTACT INFORMATION:

ir@cvsciences.com

SOURCE: CV Sciences, Inc.

View the original press release on ACCESS Newswire

FAQ

When will CV Sciences (CVSI) report Q1 2025 earnings?

CV Sciences will report Q1 2025 earnings on Wednesday, May 14, 2025, after the stock market closes.

How can investors join CV Sciences' Q1 2025 earnings call?

Investors can join via webcast at ir.cvsciences.com or dial (877) 407-0784 (U.S.) or (201) 689-8560 (international) at 4:00 p.m. Eastern Time.

What is the replay information for CVSI's Q1 2025 earnings call?

The replay will be available until May 21, 2025, by dialing (844) 512-2921 (U.S.) or (412) 317-6671 (international) with code 13753631.

What does CV Sciences (CVSI) company do?

CV Sciences is a consumer wellness company that specializes in hemp extracts and other science-backed natural ingredients and products.